First documented in the Ming Dynasty, the whole plant of Erigeron breviscapus has been used in Chinese herbal medicine for generations.
In the late '70s, people successfully extracted breviscapine from the plant, in which scutellarin was identified as the primary active flavone. Since then, breviscapine has been used as a microcirculation promoter for the treatment of cardio- and cerebrovascular diseases and has a large market share in China.
Currently, it is widely utilized as a freeze-dried powder (I.V. injectable in saline solution) and over the counter tablets with a gross revenue of over $42 million thanks to its efficacy and safety. With growing attention on breviscapine, scientific studies have revealed more beneficial effects, such as anti-oxidant, anti-inflammation, vascular relaxation, anti-platelet, anti-coagulation and myocardial protection. Learn more in this white paper.
Register to download this resource
Registering as a member of Natural Products INSIDER Digital will give you free access to premium content including digital magazines, webinars, whitepapers and more.Download